Riskpilot← Back to searchSign inGet full accessHGH, GRENAA A/S
A/SActiveCVR 33120753Kystvej 1Activities of holding companies · NACE 6421Est. 2010— employees
Revenue 2025
DKK -6K
-3% vs 2024
EBITDA margin
100.0%
+3% vs 2024
Equity ratio
—
Financial strength
Net profit 2025
DKK -1,5M
-1876% vs 2024
| Revenue | DKK -6K | -3% |
| EBITDA | DKK -6K | +3% |
| Net profit | DKK -1,5M | -1876% |
| Total assets | DKK 0 | -100% |
| Equity | DKK -790K | -210% |
| Employees | — | — |
Legal name
HGH, GRENAA A/S
CVR number
33120753
Legal form
Aktieselskab
NACE code
6421 · Activities of holding companies
Founded
25. august 2010
Share capital
DKK 1.000.000
Employees
—
VAT registered
No
Audit selected
No
Last report
2025-09-30
Financial year
January – December
Signatory rights
Selskabet tegnes af direktøren i forening med et bestyrelsesmedlem eller af den samlede bestyrelse.
Company purpose
Selskabets formål er at besidde aktier og anparter i øvrige selskaber.
Address
Kystvej 1
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -9 | -9 | -11 | — | — | — | — | — | — | — | -6 | -7 | -6 | -6 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -9 | -9 | -11 | -6 | -6 | -6 | -6 | -6 | -6 | -6 | -6 | -7 | -6 | -6 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -9 | -9 | -11 | -6 | -6 | -6 | -6 | -6 | -6 | -6 | -6 | -7 | -6 | -6 |
| Net financials | -353 | -310 | -179 | -453 | -440 | -300 | -66 | -246 | -340 | -3 | 10 | -154 | 86 | -1.501 |
| Profit before tax | -362 | -319 | -190 | -459 | -446 | -306 | -72 | -252 | -346 | -9 | 4 | -161 | 80 | -1.507 |
| Tax | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -5 | -0 |
| Net profit | -362 | -319 | -190 | -459 | -446 | -306 | -72 | -252 | -346 | -9 | 4 | -161 | 85 | -1.507 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 3.654 | 3.358 | 3.194 | 2.757 | 2.333 | 2.050 | 2.001 | 1.768 | 1.440 | 1.448 | 1.488 | 1.350 | 1.453 | 0 |
| Equity | 3.189 | 2.870 | 2.679 | 2.220 | 1.775 | 1.469 | 1.397 | 1.145 | 799 | 790 | 794 | 632 | 717 | -790 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 581 | 613 |
| Short-term debt | 465 | 489 | 514 | 536 | 558 | 581 | 604 | 622 | 641 | 658 | 694 | 718 | 155 | 176 |
| Total debt | 465 | 489 | 514 | 536 | 558 | 581 | 604 | 622 | 641 | 658 | 694 | 718 | 736 | 790 |
EBITDA margin
-612500.0%
This company
15.8%
Market median
-3876682% vs market
20122025
Equity ratio
-78969000.0%
This company
38.2%
Market median
-206725231% vs market
20122025
Return on equity
-150692700.0%
This company
18.4%
Market median
-818982165% vs market
20122025
Net profit margin
-150692700.0%
This company
8.1%
Market median
-1860403804% vs market
20122025
Asset turnover
-6125.00×
This company
1.12×
Market median
-546975% vs market
20122025
Debt / equity
1.00×
This company
0.62×
Market median
-61% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2024-10-01 – 2025-09-30
- Annual report 2024Filed via CVR / Virk · Period 2023-10-01 – 2024-09-30
- Annual report 2023Filed via CVR / Virk · Period 2022-10-01 – 2023-09-30
- Annual report 2022Filed via CVR / Virk · Period 2021-10-01 – 2022-09-30
- Annual report 2021Filed via CVR / Virk · Period 2020-10-01 – 2021-09-30
- Annual report 2020Filed via CVR / Virk · Period 2019-10-01 – 2020-09-30
- Annual report 2019Filed via CVR / Virk · Period 2018-10-01 – 2019-09-30
- Annual report 2018Filed via CVR / Virk · Period 2017-10-01 – 2018-09-30
- Annual report 2017Filed via CVR / Virk · Period 2016-10-01 – 2017-09-30
- Annual report 2016Filed via CVR / Virk · Period 2015-10-01 – 2016-09-30
- Annual report 2015Filed via CVR / Virk · Period 2014-10-01 – 2015-09-30
- Annual report 2014Filed via CVR / Virk · Period 2013-10-01 – 2014-09-30
- Annual report 2013Filed via CVR / Virk · Period 2012-10-01 – 2013-09-30
- Annual report 2012Filed via CVR / Virk · Period 2011-10-01 – 2012-09-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
TR Founder | Founder | 2010 | — | — |
LR Management | Management | 2013 | — | — |
UM Founder | Founder | 2010 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2025 | — | — | |
| Chairman | 2017 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
HGH, GRENAA A/S 
LUMAT A/SBoard members of HGH, GRENAA A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Thorkild Rørbæk Jensen | Founder | 0 companies |
| Louise Rørbæk Jensen | Management | 0 companies |
| Ulla Merethe Rørbæk Jensen | Founder | 0 companies |
| Jess Stegger | Board of Directors | 0 companies |
| Mette Rørbæk Jensen | Chairman | 0 companies |